Hypomagnesaemia – One Cause To Remember!

  • Ana Filipa Viegas Department of Internal Medicine, Centro Hospitalar Tondela-Viseu, Viseu, Portugal
  • Andreia Ferreira Moreira Lopes Department of Internal Medicine, Centro Hospitalar Tondela-Viseu, Viseu, Portugal
  • Catarina C. Almeida Department of Internal Medicine, Centro Hospitalar Tondela-Viseu, Viseu, Portugal
  • Giovana Ennis Department of Internal Medicine, Centro Hospitalar Tondela-Viseu, Viseu, Portugal
  • João Pedro Tavares Department of Internal Medicine, Centro Hospitalar Tondela-Viseu, Viseu, Portugal

Keywords

Hypomagnesaemia, proton pump inhibitors

Abstract

A 71-year-old female presented with 5 days of diarrhoea and asthenia. Past medical history of rheumatoid arthritis, arterial hypertension, hypertrophic cardiomyopathy and chronic gastritis was treated with leflunomide, deflazacort, esomeprazole, carvedilol and spironolactone. At admission, the patient’s physical examination showed signs of dehydration. Lab results revealed leucocytosis, increased C-reactive protein, hypomagnesaemia, hypocalcaemia and hypokalaemia. A presumption of acute infectious diarrhoea causing hypomagnesaemia with hypocalcaemia and hypokalaemia was made. She was started on ciprofloxacin, IV hydration and electrolyte supplementation with an adequate response. However, magnesium levels fell repeatedly. After excluding other causes for hypomagnesaemia, chronic use of proton pump inhibitors (PPIs) was considered a plausible cause therefore PPI was discontinued, with normalisation of magnesium levels.

Hypomagnesaemia is a common disturbance, mainly caused by diarrhoea, gastrointestinal malabsorption, medications, alcoholism and volume expansion. Clinical manifestations include neuromuscular symptoms, cardiovascular manifestations, hypokalaemia and changes in calcium metabolism. PPI-related hypomagnesaemia has been described in later years particularly in chronic use cases, with a medium prevalence of 27%, but further studies remain necessary to clarify its pathophysiologic mechanism. Since PPIs are widely used, it is essential to be aware of hypomagnesaemia as a possible side effect, particularly in refractory cases and after excluding other common causes.

VIEW THE ENTIRE ARTICLE

References

  • Ahmed F, Mohammed A. Magnesium: The forgotten electrolyte. a review on hypomagnesemia. Med Sci. (Basel) 2019;7:56.
  • Recart DA, Ferraris A, Petriglieri CI, Serena MA, Bonella MB, Posadas Martinez ML. Prevalence and risk factors of long-term proton pump inhibitors associated hypomagnesemia: a cross sectional study in hospitalized patients. Intern Emerg Med. 2020;16:711–717.
  • Suksridechacin N, Kulwong P, Chamniansawat S, Thongon N. Effect of prolonged omeprazole administration on segmental intestinal Mg2+ absorption in male Sprague-Dawley rats. World J Gastroenterol. 2020;26:1142–55.
  • Srinutta T, Chewcharat A, Takkavatakarn K, Praditpornsilpa K, Eiam-Ong S, Jaber BL, et al. Proton pump inhibitors and hypomagnesemia. Medicine (Baltimore). 2019;98:1–9.
  • Plaut T, Graeme K, Stigleman S, Hulkower S, Woodall T. How often does long-term PPI therapy cause clinically significant hypomagnesemia? J Fam Pract. 2018;67:576–7.
  • Published: 2022-11-11

    Issue: 2022: LATEST ONLINE (view)

    Section: Articles

    How to cite:
    1.
    Viegas AF, Moreira Lopes AF, Almeida CC, Ennis G, Tavares JP. Hypomagnesaemia – One Cause To Remember!. EJCRIM 2022;doi:10.12890/2022_003637.

    Most read articles by the same author(s)